Latest Period
n/a
Security Snapshot
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) Institutional Ownership
CUSIP: 71678J209
13F Institutional Holders and Ownership History from Q4 2022 to Q2 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Symbol
- PTPI on OTC
- Shares outstanding
- 25,296,136
- Price per share
- $0.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 71678J209.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 0 between Q1 2025 and Q2 2025.
- Reported value moved from $77,574 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
71678J209
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
PTPI full holder history
Petros Pharmaceuticals, Inc. SEC filings
Petros Pharmaceuticals, Inc. company facts
Petros Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 71678J209:
Significant Owners of Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 10% | 0% | $59,400 | +$34,129 | 5,939,954 | +135% | Iroquois Capital Management, LLC | 31 Mar 2025 |
| Ayrton Capital LLC | 6.2% | $6,576 | 657,614 | Ayrton Capital LLC | 31 Dec 2024 |
Institutional Holders of Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$77,574 | $0.01 | 0 |
| 2025 Q1 | 1,130,141 | $77,574 | +$70,830 | $0.07 | 15 |
| 2024 Q4 | 97,688 | $38,483 | -$25,561 | $0.39 | 9 |
| 2024 Q3 | 165,899 | $59,227 | -$21,303 | $0.36 | 11 |
| 2024 Q2 | 207,572 | $94,862 | +$65,263 | $0.46 | 12 |
| 2024 Q1 | 63,962 | $94,664 | -$74,791 | $1.48 | 11 |
| 2023 Q4 | 116,743 | $164,709 | +$20,587 | $1.41 | 15 |
| 2023 Q3 | 99,607 | $170,571 | -$21,147 | $1.73 | 14 |
| 2023 Q2 | 102,113 | $214,326 | +$151,856 | $2.03 | 14 |
| 2023 Q1 | 30,774 | $42,706 | -$12,589 | $1.40 | 9 |
| 2022 Q4 | 38,938 | $90,552 | +$90,552 | $2.33 | 9 |